USANA Q2 net loss $21.4M on $223M sales; cuts FY guidance, records $29M Hiya impairment

USANA HEALTH SCIENCES INC

Net loss of $21.4M (diluted EPS $(1.16)) vs net income of $9.7M ($0.52) a year ago; adjusted EPS $(0.07) vs $0.74.
Recorded $29.1M non-cash goodwill impairment on Hiya; Hiya net sales fell 17% to $28M, subscribers down 17%.
Core Nutritional net sales $192M (-4% YoY); active customers 384,000 (-8%).
FY2026 guidance slashed: consolidated net sales now $910M (prev $925M-$1.0B), net loss $(11)M (prev $20M-$27M), adj. EPS $0.76 (prev $1.95-$2.29).
Balance sheet: $169M cash, zero debt; no share repurchases in Q2; $34M remaining authorization.

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.